Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment

The bicuspid aortic valve, a kind of heart disease that comes from parents, has been paid attention around the world. Although most bicuspid aortic valve (BAV) patients will suffer from some complications including aortic stenosis, aortic regurgitation, endocarditis, and heart dysfunction in the lat...

Full description

Bibliographic Details
Main Authors: Tianshu Liu, Mingxing Xie, Qing Lv, Yuman Li, Lingyun Fang, Li Zhang, Wenhui Deng, Jing Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01921/full
_version_ 1818684528771727360
author Tianshu Liu
Tianshu Liu
Mingxing Xie
Mingxing Xie
Qing Lv
Qing Lv
Yuman Li
Yuman Li
Lingyun Fang
Lingyun Fang
Li Zhang
Li Zhang
Wenhui Deng
Wenhui Deng
Jing Wang
Jing Wang
author_facet Tianshu Liu
Tianshu Liu
Mingxing Xie
Mingxing Xie
Qing Lv
Qing Lv
Yuman Li
Yuman Li
Lingyun Fang
Lingyun Fang
Li Zhang
Li Zhang
Wenhui Deng
Wenhui Deng
Jing Wang
Jing Wang
author_sort Tianshu Liu
collection DOAJ
description The bicuspid aortic valve, a kind of heart disease that comes from parents, has been paid attention around the world. Although most bicuspid aortic valve (BAV) patients will suffer from some complications including aortic stenosis, aortic regurgitation, endocarditis, and heart dysfunction in the late stage of the disease, there is none symptom in the childhood, which restrains us to diagnose and treatment in the onset phase of BAV. Hemodynamic abnormalities induced by the malformations of the valves in BAV patients for a long time will cause BAV-associated aortopathy: including progress aortic dilation, aneurysm, dissection and rupture, cardiac cyst and even sudden death. At present, preventive surgical intervention is the only effective method used in this situation and the diameter of the aorta is the primary reference criterion for surgery. And the treatment effects are always not satisfactory for patients and clinicians. Therefore, we need more methods to evaluate the progression of BAV and the surgery value and the appropriate intervention time by combining basic research with clinical treatment. In this review, advances in morphology, genetic, biomarkers, diagnosis and treatments are summarized, which expects to provide an update about BAV. It is our supreme expectations to provide some evidences for BAV early screening and diagnosis, and in our opinion, personalized surgical strategy is the trend of future BAV treatment.
first_indexed 2024-12-17T10:52:04Z
format Article
id doaj.art-275d01f394174fe0a73bf50d1553074f
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-17T10:52:04Z
publishDate 2019-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-275d01f394174fe0a73bf50d1553074f2022-12-21T21:51:55ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2019-01-01910.3389/fphys.2018.01921433531Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and TreatmentTianshu Liu0Tianshu Liu1Mingxing Xie2Mingxing Xie3Qing Lv4Qing Lv5Yuman Li6Yuman Li7Lingyun Fang8Lingyun Fang9Li Zhang10Li Zhang11Wenhui Deng12Wenhui Deng13Jing Wang14Jing Wang15Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaDepartment of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaDepartment of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaDepartment of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaDepartment of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaDepartment of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaDepartment of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaDepartment of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaThe bicuspid aortic valve, a kind of heart disease that comes from parents, has been paid attention around the world. Although most bicuspid aortic valve (BAV) patients will suffer from some complications including aortic stenosis, aortic regurgitation, endocarditis, and heart dysfunction in the late stage of the disease, there is none symptom in the childhood, which restrains us to diagnose and treatment in the onset phase of BAV. Hemodynamic abnormalities induced by the malformations of the valves in BAV patients for a long time will cause BAV-associated aortopathy: including progress aortic dilation, aneurysm, dissection and rupture, cardiac cyst and even sudden death. At present, preventive surgical intervention is the only effective method used in this situation and the diameter of the aorta is the primary reference criterion for surgery. And the treatment effects are always not satisfactory for patients and clinicians. Therefore, we need more methods to evaluate the progression of BAV and the surgery value and the appropriate intervention time by combining basic research with clinical treatment. In this review, advances in morphology, genetic, biomarkers, diagnosis and treatments are summarized, which expects to provide an update about BAV. It is our supreme expectations to provide some evidences for BAV early screening and diagnosis, and in our opinion, personalized surgical strategy is the trend of future BAV treatment.https://www.frontiersin.org/article/10.3389/fphys.2018.01921/fullBAVmorphologygeneticsbiomarkeraortopathyvalvulopathy
spellingShingle Tianshu Liu
Tianshu Liu
Mingxing Xie
Mingxing Xie
Qing Lv
Qing Lv
Yuman Li
Yuman Li
Lingyun Fang
Lingyun Fang
Li Zhang
Li Zhang
Wenhui Deng
Wenhui Deng
Jing Wang
Jing Wang
Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment
Frontiers in Physiology
BAV
morphology
genetics
biomarker
aortopathy
valvulopathy
title Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment
title_full Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment
title_fullStr Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment
title_full_unstemmed Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment
title_short Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment
title_sort bicuspid aortic valve an update in morphology genetics biomarker complications imaging diagnosis and treatment
topic BAV
morphology
genetics
biomarker
aortopathy
valvulopathy
url https://www.frontiersin.org/article/10.3389/fphys.2018.01921/full
work_keys_str_mv AT tianshuliu bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT tianshuliu bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT mingxingxie bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT mingxingxie bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT qinglv bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT qinglv bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT yumanli bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT yumanli bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT lingyunfang bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT lingyunfang bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT lizhang bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT lizhang bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT wenhuideng bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT wenhuideng bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT jingwang bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment
AT jingwang bicuspidaorticvalveanupdateinmorphologygeneticsbiomarkercomplicationsimagingdiagnosisandtreatment